All Clinical Trials

A listing of 23142 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Trials

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Studying an Investigational Virus Vaccine

Recruiting

The main objectives of this study are to assess the safety and effectiveness of an investigational vaccine aimed at preventing norovirus, commonly known as the stomach flu. Participants will be randomly assigned to receive either the investigational vaccine or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.

Conditions:

Healthy

Interested in vaccine studies

All Conditions

Preventative Trials

Learn More

Featured Trial

Type 2 Diabetes Clinical Trial

Recruiting

Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.

Conditions:

Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

Diabetes Type Two

Type 2 Diabetes Mellitus

Diabete Type 2

Learn More

Featured Trial

Evaluating an Investigational Treatment for Hidradenitis Suppurativa

Recruiting

The main objectives of this Phase 2 study are to evaluate the safety and effectiveness of an investigational medication in adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition. Participants will be randomly assigned to receive the investigational treatment or a placebo. Should you express interest, the research site will contact you directly to provide further details and address any questions you may have about study requirements, risks/benefits, and compensation.

Conditions:

All Conditions

Hidradenitis suppurativa (Skin disorder)

Dermatology

Learn More

Featured Trial

Crohn's Disease Clinical Study

Recruiting

Help us study a potential new way to treat Crohn's disease. We are seeking adults living with Crohn's disease to join our latest clinical trial to help us learn more. Eligible participants will receive study-related treatment, assessments, and care at no cost. You will also receive reimbursement for travel while participating. Health insurance is not required to take part.

Conditions:

Crohn's Disease

Crohn Disease

Crohns Disease

Crohn's Disease (CD)

Crohn Colitis

Learn More

Featured Trial

Studying an Investigational Medication's Impact on Cardiovascular Events

Recruiting

The main objectives of this Phase 3 study are to evaluate the safety and effectiveness of an investigational medication's ability to reduce major adverse cardiovascular events (such as heart attacks and strokes) in adults at risk. Participants will be randomly assigned to receive either the investigational medication or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.

Conditions:

All Conditions

Hyperlipidemia

Cardiovascular Disease

Ischemic heart disease (IHD)

Stroke

Learn More

Penn Medicine Healthy Heart

NCT06062394

Recruiting

To leverage access to patients across the primary care network, EPIC tools for identifying eligible patients, and the Way to Health platform to launch and enroll a program that will be evaluated in a clinical trial that is focused on changing patient behavior and powered to detect differences in improving blood pressure and cholesterol over 6 months for Penn Medicine patients in West/Southwest Philadelphia and Lancaster.

Gender:

ALL

Ages:

Between 35 years and 80 years

Trial Updated:

04/17/2025

Locations: Penn Medicine, Philadelphia, Pennsylvania

Conditions: Hypertension, Hyperlipidemias

Learn More ›

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE

NCT06174805

Recruiting

To investigate the safety and technical success of EUS-guided gastroenterostomy (EUS-GE) using the AXIOSTM lumen-apposing Metal Stent for the management of symptoms associated with gastric outlet obstruction from malignant unresectable neoplasm.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/17/2025

Locations: Brigham and Women's Hospital, Boston, Massachusetts +9 locations

Conditions: Gastric Outlet Obstruction

Learn More ›

Observational Study of Oral Cariprazine Capsules to Assess Change in Disease Activity in Adult Participants With Bipolar I Disorder

NCT06256367

Recruiting

Bipolar I disorder (BP-I) is a common, chronic, and disabling mental illness with significant morbidity and mortality defined by episodes of mania and depression (or symptoms of both at once, known as mixed features). This prospective, observational study will examine effectiveness, functioning and quality of life outcomes in adult patients with BP-I experiencing a major depressive episode (with or without mixed features) requiring treatment and initiating treatment with cariprazine. It will exa... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/17/2025

Locations: University of Alabama at Birmingham - Main /ID# 260000, Birmingham, Alabama +18 locations

Conditions: Bipolar I Disorder

Learn More ›

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT06291220

Recruiting

Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries. The purpose of this study is to assess how well ABBV-453 works adult participants with relapsed/refractory (R/R) untreated CLL/small lymphocytic lymphoma (SLL). Adverse events, pharmacokinetics, and change in disease activity will be assessed. ABBV-453 is an investigational drug for the treatment of CLL and SLL. There are 2 parts to this study. In part A participants will be placed 1 of 5 cohorts with a specific target dose for each cohort and receive obinutuzumab during the debulking period followed escalating doses of ABBV-453, until the appropriate target dose is achieved. In part B participants will be placed in 2 cohorts and receive up to the maximum dose in part A, with cohort 2.1 including a debulking period (obinutuzumab) as in part A. Approximately 80 adult participants with previously R/R CLL/SLL will be enrolled in the study in approximately 40 sites across the world. Participants in part A will placed into 1 of 5 cohorts with a specific target dose for each cohort and will receive intravenous (IV) obinutuzumab as part of the debulking period, followed by escalating doses of oral ABBV-453 until the appropriate target dose is achieved. Participants in part B will be place in one of 2 cohorts. Participants in cohort 2.1 will receive IV obinutuzumab as part of the debulking period, followed by escalating doses of oral ABBV-453 until the maximum target dose from part A is achieved. Participants in cohort 2.2 will receive no treatment during the the debulking period, followed by escalating doses of oral ABBV-453 until the maximum target dose from part A is achieved. The estimated study duration is 5 years. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, and checking for side effects. Read Less

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/17/2025

Locations: City of Hope /ID# 253904, Duarte, California +20 locations

City of Hope /ID# 253904, Duarte, California

City of Hope Orange County Lennar Foundation Cancer Center /ID# 267158, Irvine, California

Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana /ID# 264622, Billings, Montana

Atrium Health /ID# 265136, Charlotte, North Carolina

Duke Cancer Center /ID# 258707, Durham, North Carolina

MD Anderson Cancer Center /ID# 253713, Houston, Texas

Royal Prince Alfred Hospital /ID# 263129, Sydney, New South Wales

Gold coast University Hospital /ID# 255785, SouthPort, Queensland

Austin Health /ID# 256776, Heidelberg, Victoria

Royal Perth Hospital /ID# 256464, Perth, Western Australia

Universitaetsklinikum Ulm /ID# 263148, Ulm, Baden-Wuerttemberg

Universitaetsklinikum Schleswig-Holstein - Campus Kiel /ID# 263150, Kiel, Schleswig-Holstein

Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin /ID# 263433, Berlin, Not set

Universitaetsklinikum Halle (Saale) /ID# 263299, Halle (Saale), Not set

Universitaetsklinikum Hamburg-Eppendorf /ID# 263730, Hamburg, Not set

Yitzhak Shamir Medical Center /ID# 257626, Zerifin, HaMerkaz

The Chaim Sheba Medical Center /ID# 254383, Ramat Gan, Tel-Aviv

Hadassah Medical Center-Hebrew University /ID# 254721, Jerusalem, Yerushalayim

IRCCS Ospedale San Raffaele /ID# 263064, Milan, Milano

IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 263065, Bologna, Not set

Azienda Ospedaliera di Perugia - Ospedale S. Maria della Misericordia /ID# 263062, Perugia, Not set

Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Learn More ›

A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

NCT06360094

Recruiting

Adults 40 years of age and older with idiopathic pulmonary fibrosis (IPF) or 18 years and older with progressive pulmonary fibrosis (PPF) can participate in this study. Only people who have a chronic cough can take part. The purpose of this study is to find out how well BI 1839100 helps reduce coughing in people with IPF or PPF. Participants who have IPF are put into 4 groups by chance. Participants in 3 groups get different doses of BI 1839100. Participants in 1 group get placebo. Placebo look... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/17/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +179 locations

University of Alabama at Birmingham, Birmingham, Alabama

Critical Care, Pulmonary and Sleep Associates, Lakewood, Colorado

Clinical Research Specialists LLC, Kissimmee, Florida

Northwestern University, Chicago, Illinois

The Iowa Clinic, PC, West Des Moines, Iowa

Advanced Pulmonary Research, Warren, Michigan

Memorial Hospital Gulfport, Gulfport, Mississippi

Renown Regional Medical Center, Reno, Nevada

Northern Westchester Hospital, Mount Kisco, New York

Icahn School of Medicine at Mount Sinai, New York, New York

Columbia University Medical Center-New York Presbyterian Hospital, New York, New York

Duke University Medical Center, Durham, North Carolina

Coastal Carolina Health Care, P.A. Pulmonary and Sleep Medicine, New Bern, North Carolina

Southeastern Research Center-Winston Salem-69289, Winston-Salem, North Carolina

University of Oklahoma-Oklahoma City-59108, Oklahoma City, Oklahoma

Clinical Research Associates of Central PA, DuBois, Pennsylvania

Temple University Hospital, Philadelphia, Pennsylvania

Lowcountry Lung and Critical Care, Charleston, South Carolina

Spartanburg Medical Research, Spartanburg, South Carolina

A & A Research Consultants, LLC, Edinburg, Texas

University of Utah Health Sciences Center, Salt Lake City, Utah

Pulmonary Associates of Richmond, Inc., Richmond, Virginia

Centro de Investigaciones Metabolicas (CINME)-C.A.B.A-61553, C.a.b.a, Not set

Hospital Britanico de Buenos Aires, Caba, Not set

Centro de Investigación Clinica Belgrano, Caba, Not set

CEDIC - Centro de Investigacion Clinica, Caba, Not set

Consultorios Médicos del Buen Ayre, Capital Federal, Not set

Canberra Hospital, Canberra, Australian Capital Territory

Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales

Macquarie University, Macquarie Park, New South Wales

Launceston Respiratory & Sleep Centre, Launceston, Tasmania

Lung Research Victoria, Footscray, Victoria

Austin Hospital, Heidelberg, Victoria

The Alfred Hospital, Melbourne, Victoria

Institute for Respiratory Health, Nedlands, Western Australia

Medical University of Graz State Hospital - University Hospital Graz, Graz, Not set

Krems University Hospital, Krems, Not set

Kepler Univ. Klinikum Linz, Linz, Not set

Hospital Elisabethinen Linz, Linz, Not set

Clinic Floridsdorf, Vienna, Not set

Klinikum Wels - Grieskirchen GmbH, Wels, Not set

Brussels - UNIV Saint-Luc, Bruxelles, Not set

UNIV UZ Gent, Gent, Not set

Centre Hospitalier Universitaire de Liège, Liège, Not set

Liège - HOSP CHR de la Citadelle, Liège, Not set

Serviços Medicos Respirar Sul Fluminense, Barra Mansa, Not set

Faculdade de Medicina de Botucatu - UNESP, Botucatu, Not set

CLARE - Clinica de Pneumologia, Goiania, Not set

Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Not set

Netspiro Clinica Medica Ltda - Respsono, Sao Bernardo do Campo, Not set

Hospital Alemao Oswaldo Cruz, Sao Paulo, Not set

Hospital das Clinicas da FMUSP, São Paulo, Not set

Gordon & Leslie Diamond Health Care Centre (UBC), Vancouver, British Columbia

St. Paul's Hospital (Vancouver), Vancouver, British Columbia

St. Joseph's Healthcare Hamilton, Hamilton, Ontario

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec

CIC Mauricie Inc., Trois-Rivieres, Quebec

Beijing Chao-Yang Hospital, Beijing, Not set

The Second Xiangya Hospital Of Central South University, Changsha, Not set

West China Hospital, Chengdu, Not set

People's Hospital of Sichuan Province, Chengdu, Not set

First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Not set

Hangzhou First People's Hospital, Hangzhou, Not set

Zhejiang Hospital, Hangzhou, Not set

Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, Not set

Anhui Provincial Hospital, Hefei, Not set

Nanjing Drum Tower Hospital, Nanjing, Not set

Shanghai Chest Hospital, Shanghai, Not set

Shanghai Pulmonary Hospital, Shanghai, Not set

China Shenyang Chest Hospital, Shenyang, Not set

Tianjin Medical University General Hospital, Tianjin, Not set

Affiliated Hospital, Xuzhou Medical college, Xuzhou, Not set

Thomayer University Hospital, Prague, Not set

Odense University Hospital, Odense, Not set

HYKS Keuhkosairauksien tutkimusyksikkö, Helsinki, Not set

Oulun yliopistollinen keskussairaala, Oulu, Not set

TYKS, Turku, Not set

HOP d'Angers, Angers, Not set

HOP Avicenne, Bobigny, Not set

HOP CHU Caen, Caen, Not set

HOP Michallon, La Tronche, Not set

INS Coeur Poumon, Lille, Not set

HOP Nord, Marseille, Not set

HOP Nord Laennec, Nantes, Not set

HOP Bichat, Paris, Not set

HOP Haut-Lévêque, Pessac, Not set

HOP Charles Nicolle, Rouen, Not set

HOP Bretonneau, Tours, Not set

Universitätsklinikum Aachen, AöR, Aachen, Not set

CIMS Studienzentrum Bamberg GmbH, Bamberg, Not set

Vivantes Netzwerk für Gesundheit GmbH, Berlin, Not set

Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH, Essen, Not set

Universitätsklinikum Freiburg, Freiburg, Not set

Universitätsklinikum Hamburg, Eppendorf, Hamburg, Not set

Medizinische Hochschule Hannover, Hannover, Not set

Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg, Heidelberg, Not set

Krankenhaus Bethanien gGmbH, Solingen, Not set

Helios Hanseklinikum Stralsund, Stralsund, Not set

Robert Bosch Gesellschaft für medizinische Forschung mbH, Stuttgart, Not set

Klinikum Würzburg Mitte gGmbH, Würzburg, Not set

Univ. Gen. Hosp. of Ioannina, Ioannina, Not set

Univ. Gen. Hosp. of Patras, Patras, Not set

Hospital of Heraklion (PAGNI), Voutes, Not set

Koranyi National Institute For Pulmonolgy, Budapest, Not set

A. O. Universitaria Careggi, Firenze, Not set

Ospedale Colonnello D Avanzo, Foggia, Not set

Ospedale G.B. Morgagni, Forli', Not set

Azienda Ospedaliera San Martino, Genova, Not set

Ospedale Classificato San Giuseppe, Milano, Not set

Azienda Ospedaliera Universitaria di Padova, Padova, Not set

Pol. Universitario Tor Vergata, Roma, Not set

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Not set

Azienda Ospedaliera Sant'Andrea-Università di Roma La Sapienza, Roma, Not set

Tosei General Hospital, Aichi, Seto, Not set

Chiba University Hospital, Chiba, Chiba, Not set

University of Fukui Hospital, Fukui, Yoshida-gun, Not set

National Hospital Organization Kyushu Medical Center, Fukuoka, Fukuoka, Not set

Kyushu University Hospital, Fukuoka, Fukuoka, Not set

Sapporo Medical University Hospital, Hokkaido, Sapporo, Not set

National Hospital Organization Himeji Medical Center, Hyogo, Himeji, Not set

Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Yokohama, Not set

Nagasaki University Hospital, Nagasaki, Nagasaki, Not set

National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Sakai, Not set

Hamamatsu University Hospital, Shizuoka, Hamamatsu, Not set

Tokushima University Hospital, Tokushima, Tokushima, Not set

Kyorin University Hospital, Tokyo, Mitaka, Not set

Toho University Omori Medical Center, Tokyo, Ota-ku, Not set

National Center for Global Health and Medicine, Tokyo, Shinjuku-ku, Not set

The Catholic University of Korea, Bucheon St.Mary's Hospital, Bucheon, Not set

Inje University Haeundae Paik Hospital, Busan, Not set

Seoul National University Bundang Hospital, Seongnam, Not set

Inje University Sanggye Paik Hospital, Seoul, Not set

Kyung Hee University Hospital, Seoul, Not set

Severance Hospital, Seoul, Not set

Soonchunhyang University Hospital Seoul, Seoul, Not set

Asan Medical Center, Seoul, Not set

Hospital Sultan Idris Shah Serdang, Kajang, Not set

Institut Perubatan Respiratori, Kuala Lumpur, Not set

Sarawak General Hospital, Kuching, Sarawak, Not set

Amphia Ziekenhuis, Breda, Not set

Erasmus Medisch Centrum-ROTTERDAM-50697, Rotterdam, Not set

Christchurch Hospital, Christchurch, Not set

Waikato Hospital, Hamilton, Not set

Greenlane Clinical Centre, One Tree Hill, Auckland, Not set

Haukeland Universitetssykehus, Bergen, Not set

Akershus Universitetssykehus HF, Lørenskog, Not set

Oslo Universitetssykehus HF, Rikshospitalet, Oslo, Not set

University Clinical Hospital in Bialystok I, Bialystok, Not set

Alergopneuma Medical Center, Swidnik, Not set

Nat.Instit.of Tuberculosis&LungDiseases,Outpat.Clin,warszawa, Warsaw, Not set

Singapore General Hospital, Singapore, Not set

Tan Tock Seng Hospital, Singapore, Not set

Hospital General Universitario de Alicante, Alicante, Not set

Hospital Vall d'Hebron, Barcelona, Not set

Hospital de Galdakao, Galdakao, Not set

Hospital de Bellvitge, L'Hospitalet de Llobregat, Not set

Hospital Universitario Infanta Leonor, Madrid, Not set

Hospital Virgen de la Victoria, Malaga, Not set

Hospital Central de Asturias, Oviedo, Not set

Hospital Quirónsalud Madrid, Pozuelo de Alarcón, Not set

Hospital Universitario Marqués de Valdecilla, Santander, Not set

Hospital Clínico de Santiago, Santiago de Compostela, Not set

Hospital Virgen del Rocío, Sevilla, Not set

Skånes universitetssjukhus, Lund, Lund, Not set

CTC Clinical Trial Consultants AB, Uppsala, Not set

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set

Taichung Veterans General Hospital, Taichung, Not set

National Taiwan University Hospital, Taipei, Not set

Chang Gung Memorial Hospital(Linkou), TaoYuan, Not set

Chulalongkorn Hospital, Bangkok, Not set

Srinagarind Hospital, Khon Kaen, Not set

Ramathibodi Hospital, Ratchatewi, Not set

Songklanagarind Hospital, Songkhla, Not set

Castle Hill Hospital, Cottingham, Not set

Royal Devon and Exeter Hospital, Wonford, Exeter, Not set

Royal Lancaster Infirmary, Lancaster, Not set

Royal Brompton Hospital, London, Not set

Wythenshawe Hospital, Manchester, Not set

Southampton General Hospital, Southampton, Not set

Conditions: Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis

Learn More ›

Wisconsin Ginseng for Decreasing Cancer Related Fatigue

NCT06395441

Recruiting

This phase III trial compares the effect of Wisconsin ginseng (panax quinquefolius) to placebo in patients with cancer that suffer from significant fatigue. Fatigue is among the most challenging symptoms to manage in patients with cancer, both on or off active treatment. This symptom complex meaningfully contributes to psychosocial distress, healthcare costs, and it also interferes with the delivery of anticancer therapies. American ginseng (Western ginseng) appears to be a promising appearing a... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/17/2025

Locations: Mayo Clinic Health System in Albert Lea, Albert Lea, Minnesota +14 locations

Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

Learn More ›

Study of SPG302 in Adults With Schizophrenia

NCT06442462

Recruiting

This Phase 2 study described herein will evaluate the safety, efficacy, tolerability, and pharmacodynamics of SPG302 in adults with a primary diagnosis of schizophrenia.

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

04/17/2025

Locations: CenExel CNS, Garden Grove, California +2 locations

Conditions: Schizophrenia

Learn More ›

A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

NCT06538116

Recruiting

The main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer Disease (AD) dementia. This is done by looking at participants: thinking and memory (cognition), everyday activities and sleep, AD symptoms, physical activity, irritability or anxiety. The study is expected to last approximately 26 weeks and may include up to 14 visits.

Gender:

ALL

Ages:

Between 50 years and 80 years

Trial Updated:

04/17/2025

Locations: Banner Alzheimer's Institute, Phoenix, Arizona +63 locations

Banner Alzheimer's Institute, Phoenix, Arizona

Baptist Health Center for Clinical Research, Little Rock, Arkansas

Profound Research, LLC, Carlsbad, California

Neuro-Pain Medical Center, Fresno, California

Catalina Research Institute, LLC, Montclair, California

California Neuroscience Research Medical Group, Inc., Sherman Oaks, California

JEM Research Institute, Atlantis, Florida

Visionary Investigators Network, Aventura, Florida

Excel Medical Clinical Trials, Boca Raton, Florida

Vertex Clinical Research, Clermont, Florida

Neuropsychiatric Research Center of Southwest Florida, Fort Myers, Florida

Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Jacksonville, Florida

Merritt Island Medical Research, LLC, Merritt Island, Florida

Visionary Investigators Network, Miami, Florida

Suncoast Clinical Research, New Port Richey, Florida

Renstar Medical Research, Ocala, Florida

Charter Research, Orlando, Florida

Progressive Medical Research, Port Orange, Florida

Intercoastal Medical Group - Hyde Park, Sarasota, Florida

Brain Matters Research, Stuart, Florida

Charter Research, LLC, The Villages, Florida

Premiere Research Institute at Palm Beach Neurology, West Palm Beach, Florida

Conquest Clinical Research, LLC, Winter Park, Florida

CenExel iResearch, LLC, Decatur, Georgia

NeuroStudies, Decatur, Georgia

CenExel iResearch, LLC, Savannah, Georgia

Hawaii Pacific Neuroscience, Honolulu, Hawaii

Alexian Brothers Medical Center, Elk Grove Village, Illinois

Josephson Wallack Munshower Neurology, PC, Indianapolis, Indiana

ActivMed Practices and Research, Methuen, Massachusetts

QUEST Research Institute, Farmington Hills, Michigan

Be Well Clinical Studies, Lincoln, Nebraska

CenExel Advanced Memory Research Institute of NJ, Toms River, New Jersey

AMC Research, Matthews, North Carolina

Eximia Research-NC, LLC, Raleigh, North Carolina

Keystone Clinical Studies, Plymouth Meeting, Pennsylvania

Clinical Neuroscience Solutions Inc, Memphis, Tennessee

Cedar Health Research LLC, Arlington, Texas

Senior Adults Specialty Research, Austin, Texas

Kerwin Medical Center, Dallas, Texas

Clinical Trial Network, Houston, Texas

El Faro Health and Therapeutics, Rio Grande City, Texas

Clinical Trials of Texas, Inc., San Antonio, Texas

University of Washington - Harborview Medical Center, Seattle, Washington

National Center for Geriatrics and Gerontology, Obu, Aichi

Mabashi Clinic, Matsudo-shi, Chiba-Ken

Inage Neurology and Memory Clinic, Inage, Chiba

Mental Clinic Sakurazaka, Fukuoka-shi, Fukuoka-Ken

Kuramitsu Hospital, Fukuoka-shi, Fukuoka-ken

Southern TOHOKU Medical Clinic, Koriyama-shi, Fukushima-Ken

Ikuseikai Shinozuka Hospital, Fujioka-shi, Gunma-Ken

Medical Corporation Kishikai Kishi Hospital, Kiryu-shi, Gunma-Ken

Cocoro Hospital Kusatsu, Hiroshima-shi, Hiroshima-Ken

Himeji Central Hospital Affiliated Clinic, Himeji, Hyogo

Memory Clinic Toride, Toride, Ibaraki

Oita University Hospital, Yufu, Oita

Katayama Medical Clinic, Kurashiki, Okayama

NHO Hizen Psychiatric Center, Kanzaki-gun, Saga-Ken

Rainbow & Sea Hospital, Karatsu-shi, Saga-Ken

Memory Clinic Ochanomizu, Bunkyo-ku, Tokyo

Tokyo Medical University Hospital, Shinjuku-ku, Tokyo

Akita City Hospital, Akita, Not set

Tokyo Metro Bokutoh Hospital, Sumida-ku, Not set

Yamagata University Hospital, Yamagata, Not set

Conditions: Alzheimer Disease

Learn More ›

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT06588478

Recruiting

The main purpose of this study is to assess the efficacy and safety of 3 dose levels of Pirtobrutinib in participants with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), who have received 1-3 lines of treatment including a covalent Bruton tyrosine kinase (BTK) inhibitor. The study is expected to last approximately 3 years.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/17/2025

Locations: Ironwood Cancer & Research Centers, Chandler, Arizona +136 locations

Ironwood Cancer & Research Centers, Chandler, Arizona

City of Hope National Medical Center, Duarte, California

City of Hope National Medical Center, Irvine, California

Palo Alto Medical Foundation Research Institute (PAMFRI), Palo Alto, California

Stanford Cancer Center, Palo Alto, California

Rocky Mountain Cancer Center, Aurora, Colorado

University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami, Florida

City of Hope National Medical Center, Atlanta Cancer Center, Newnan, Georgia

Mission Cancer + Blood, Waukee, Iowa

Saint Elizabeth Medical Center Edgewood, Edgewood, Kentucky

American Oncology Partners of Maryland, PA, Bethesda, Maryland

Boston Medical Center, Boston, Massachusetts

Gulfport Memorial Hospital, Gulfport, Mississippi

Clinical Research Alliance, Westbury, New York

East Carolina University, Greenville, North Carolina

Williamette Valley Cancer Institute & Research Center, Eugene, Oregon

Cancer Care Associates Of York, York, Pennsylvania

The West Clinic, PLLC dba West Cancer Center, Germantown, Tennessee

USO-Texas Oncology-Central/South Texas, Austin, Texas

Sarah Cannon Research Institute/SCRI, The Woodlands, Texas

USO-Virginia Oncology Associates, Hampton, Virginia

USO-Northwest Cancer Specialists, PC, Vancouver, Washington

Bankstown-Lidcombe Hospital, Bankstown, New South Wales

Coffs Harbour Health Campus, Coffs Harbour, New South Wales

Calvary Mater Newcastle, Waratah, New South Wales

Princess Alexandra Hospital, Woolloongabba, Queensland

Flinders Medical Centre, Adelaide, South Australia

ICON Cancer Centre - Kurralta Park, Kurralta Park, South Australia

Royal Hobart Hospital, Hobart, Tasmania

Box Hill Hospital, Box Hill, Victoria

Latrobe Regional Health, Traralgon, Victoria

The Perth Blood Institute - West Perth, West Perth, Western Australia

Clinique Saint Pierre, Ottignies, Brabant Wallon

Institut Jules Bordet, Anderlecht, Bruxelles-Capitale, Région De

Groupe Jolimont, La Louvière, Hainaut

CHR Verviers - La Tourelle, Verviers, Liège

UZ Gent, Gent, Oost-Vlaanderen

AZ Nikolaas, Sint-Niklaas, Oost-Vlaanderen

UZ Leuven, Leuven, Vlaams-Brabant

AZ Sint-Jan Brugge-Oostende AV, Brugge, West-Vlaanderen

AZ Delta vzw, Roeselare, West-Vlaanderen

Royal Victoria Regional Health Centre, Barrie, Ontario

CIUSSS- saguenay-Lac-Saint-Jean, Chicoutimi, Quebec

Saskatoon Cancer Centre, Saskatoon, Saskatchewan

Fakultní nemocnice Brno Bohunice, Brno, Brno-město

Fakultni nemocnice Hradec Kralove, Hradec Kralove, Hradec Králové

Fakultni nemocnice Kralovske Vinohrady, PRague, Praha 10

Vseobecna fakultni nemocnice v Praze, Praha 2, Not set

Aarhus Universitetshospital, Skejby, Aarhus, Midtjylland

Odense Universitetshospital, Odense, Syddanmark

Centre Antoine-Lacassagne, Nice, Alpes-Maritimes

Groupe Hospitalier de la Région de Mulhouse et Sud Alsace - Hôpital Emile Muller, Mulhouse, Alsace

Centre Hospitalier Universitaire de Caen - Hôpital Côte de Nacre, Caen, Calvados

Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE, Toulouse, Haute-Garonne

Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau, Tours, Indre-et-Loire

Centre Hospitalier du Mans, Le Mans, Sarthe

Centre Hospitalier d'Argenteuil Victor Dupouy, Argenteuil, Val-d'Oise

Klinikum Aschaffenburg-Alzenau, Aschaffenburg, Bayern

Centrum für Hämatologie und Onkologie Bethanien, Frankfurt, Hessen

OSP Göttingen, Goettingen, Niedersachsen

Onkologisches Ambulanzzentrum Hannover, Hannover, Niedersachsen

MV-Zentrum für Onkologie und Hämatologie, Cologne, Nordrhein-Westfalen

InVO Institut für Versorgungsforschung in der Onkologie, Koblenz, Rheinland-Pfalz

Evangelismos General Hospital of Athens, Athens, Attikí

Attikon General University Hospital, Chaidari, Attikí

General Hospital of Athens "Laiko", Αthens, Attikí

G. Papanikolaou General Hospital, Thessaloniki, Thessaloníki

Pécsi Tudományegyetem Klinikai Központ, Pécs, Baranya

Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ, Szeged, Csongrád

Semmelweis Egyetem, Budapest, Not set

Dél-Pesti Centrumkórház, Budapest, Not set

Azienda Ospedaliero Universitaria S.Anna, Cona, Emilia-Romagna

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore, Roma, Lazio

ASST Grande Ospedale Metropolitano Niguarda, Milan, Lombardia

A.O.U.C. Policlinico di Bari, Bari, Puglia

Az. Osp. Ospedali Riuniti VILLA SOFIA-CERVELLO, Palermo, Sicilia

Azienda Ospedaliera Universitaria Careggi, Firenze, Toscana

AO Santa Maria della Misericordia, Perugia, Umbria

Azienda Ospedale - Università Padova, Padova, Veneto

Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Not set

AOU Policlinico Umberto I, Roma, Not set

Chonnam National University Hwasun Hospital, Hwasun-gun, Jeonranamdo

Pusan National University Hospital, Busan, Pusan-Kwangyǒkshi

Seoul National University Hospital, Seoul, Seoul-teukbyeolsi [Seoul]

Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul]

The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul]

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu, Wrocław, Dolnośląskie

IN VIVO, Bydgoszcz, Kujawsko-pomorskie

Pratia MCM Krakow, Kraków, Małopolskie

AIDPORT Sp. z o.o., Skórzewo, Wielkopolskie

Pratia Onkologia Katowice, Katowice, Śląskie

Fundeni Clinical Institute, Bucuresti, București

Ovidius Clinical Hospital OCH, Ovidiu, Constanța

Spitalul Clinic Municipal Filantropia Craiova, Craiova, Dolj

Spitalul Clinic Colțea, București, Not set

Institutul Oncologic Cluj, Cluj, Not set

Institutul Regional de Oncologie, Iași, Not set

Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica, Banska Bystrica, Banskobystrický Kraj

Narodny onkologicky ustav, Bratislava, Bratislavský Kraj

Univerzitna Nemocnica L. Pasteura Kosice, Kosice, Košický Kraj

Univerzitna nemocnica Martin, Martin, Žilinský Kraj

Hospital Universitario Virgen Macarena, Sevilla, Andalucía

Hospital Universitario Central de Asturias, Oviedo, Asturias

Institut Català d'Oncologia (ICO) - Badalona, Badalona, Barcelona [Barcelona]

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]

Institut Català d'Oncologia - L'Hospitalet, L'Hospitalet Del Llobregat, Barcelona [Barcelona]

Hospital Universitario Marqués de Valdecilla, Santander, Cantabria

Hospital Clínic de Barcelona, Barcelona, Catalunya [Cataluña]

Clinica Universidad de Navarra, Madrid, Madrid, Comunidad De

Hospital Universitario Infanta Leonor, Madrid, Madrid, Comunidad De

MD Anderson Cancer Center, Madrid, Madrid, Comunidad De

Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad De

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad De

Hospital Costa del Sol, Marbella, Málaga

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario Quironsalud Madrid, Madrid, Not set

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca, Not set

Hospital Universitario Virgen Del Rocio, Sevilla, Not set

Kocaeli Üniversitesi, Izmit, Kocaeli

Sakarya University School of Medicine, Adapazarı, Sakarya

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi, Ankara, Not set

Ankara University Health Practice and Research Hospitals, Ankara, Not set

Memorial Antalya Hospital, Antalya, Not set

Yeditepe Üniversitesi Koşuyolu Hastanesi, Istanbul, Not set

Ege Universitesi Hastanesi, Izmir, Not set

VM Medical Park Mersin Hastanesi, Mersin, Not set

Ondokuz Mayıs Universitesi, Samsun, Not set

Maidstone Hospital, Maidstone, Kent

Lincoln County Hospital, Lincoln, Lincolnshire

Northwick Park Hospital, Harrow, London, City Of

Hammersmith Hospital, London, London, City Of

Heartlands Hospital, Birmingham, Not set

The Beatson West of Scotland Cancer Centre, Glasgow, Not set

St James's University Hospital, Leeds, Not set

Clatterbridge Cancer Centre - Liverpool, Liverpool, Not set

Singleton Hospital, Swansea, Not set

Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Learn More ›

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

NCT06607185

Recruiting

The main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combination with other treatments. The study will have 2 parts: monotherapy dose escalation and dose optimization. The study is expected to last up to approximately 5 years.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/17/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +51 locations

University of Alabama at Birmingham, Birmingham, Alabama

Mayo Clinic, Phoenix, Arizona

City of Hope, Duarte, California

University of California, Los Angeles (UCLA), Los Angeles, California

University of Colorado Denver, Denver, Colorado

Yale University School of Medicine - Yale Cancer Center, New Haven, Connecticut

The University of Chicago Medical Center (UCMC), Chicago, Illinois

Indiana University (IU), Indianapolis, Indiana

Massachusetts General Hospital, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

Henry Ford Health System, Detroit, Michigan

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids, Michigan

Mayo Clinic - Rochester, Rochester, Minnesota

Columbia University, New York, New York

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York

Duke University Medical Center, Durham, North Carolina

Cleveland Clinic, Cleveland, Ohio

University of Oklahoma - Health Sciences Center, Oklahoma City, Oklahoma

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

SCRI Oncology Partners, Nashville, Tennessee

University of Texas Southwestern, Dallas, Texas

MD Anderson Cancer Center, Houston, Texas

South Texas Accelerated Research Therapeutics (START), San Antonio, Texas

Virginia Cancer Specialists, Fairfax, Virginia

Swedish Cancer Institute (SCI), Seattle, Washington

Universite Libre de Bruxelles (ULB) - Institut Jules Bordet, Brussels, Not set

Cliniques universitaires Saint-Luc, Brussels, Not set

University Hospital Gent, Gent, Not set

Shandong Province Tumor Hospital, Jinan, Not set

Shanghai East Hospital, Tongji University, Shanghai, Not set

Centre Leon Berard, Lyon, Not set

Institut Gustave Roussy, Villejuif cedex, Not set

Charite Universitaetsmedizin Berlin, Berlin, Not set

Krankenhaus Nordwest GmbH, Frankfurt, Not set

Asklepios Kliniken Hamburg GmbH - Asklepios Klinik Altona, Hamburg, Not set

SLK-Kliniken Heilbronn GmBH, Heilbronn, Not set

Universitaetsklinikum Wuerzburg, Wuerzburg, Not set

Centro Ricerche Cliniche di Verona s.r.l., Verona, Not set

National Cancer Center Hospital East, Kashiwa, Chiba, Not set

Kyoto University Hospital, Kyoto, Not set

Shizuoka Cancer Center, Shizuoka, Not set

National Cancer Center Hospital, Tokyo, Not set

Cancer Institute Hospital of JFCR, Tokyo, Not set

Hospital del Mar, Barcelona, Not set

Hospital Universitario Vall d'Hebron, Barcelona, Not set

Institut Catala d'Oncologia - L'Hospitalet, Barcelona, Not set

Hospital General Universitario Gregorio Maranon, Madrid, Not set

Hospital Universitario Ramon y Cajal, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Regional Universitario de Malaga, Malaga, Not set

National Taiwan University Hospital Hsin-Chu Branc, Hsinchu, Not set

National Taiwan University Hospital, Taipei, Not set

Conditions: Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer, Advanced Solid Tumor, Metastatic Solid Tumor

Learn More ›

Safety of Anal Curcumin

NCT06626230

Recruiting

The purpose of this study is to see if curcumin can reverse anal high-grade squamous intraepithelial lesions (aHSIL) (high-grade anal precancerous cells or high-grade abnormal cells) in people living with HIV to avoid current treatments such as ablation (destroying abnormal cells with heat or surgical excision (cutting out the abnormal cells)), which have potential short- and long-term side effects.

Gender:

ALL

Ages:

30 years and above

Trial Updated:

04/17/2025

Locations: Grady Memorial Hospital, Atlanta, Georgia +1 locations

Conditions: Anal High Grade Squamous Intraepithelial Lesion

Learn More ›

Nutrient Profile and Muscle Protein Synthesis in Response to Corn Bread Made From Refined Versus Whole Grain Maize Flour

NCT06662214

Recruiting

The purpose of the study is to quantify and compare the serum nutrient and hormonal profile, and muscle protein synthesis rates, in response to consuming isonitrogenous amounts of a traditional East African meal, mung bean stew with a traditional African corn bread made from two different kinds of maize (whole corn flour or refined). Specific aim 1: Describe the post-prandial nutrient and hormonal profile in serum in the 3 hours following consumption of a portion of mung bean stew with traditio... Read More

Gender:

ALL

Ages:

Between 18 years and 30 years

Trial Updated:

04/17/2025

Locations: UC Davis CTSC Clinical Research Center, Sacramento, California

Conditions: Effect of Food

Learn More ›